XML 53 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended 124 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Cash flows from operating activities:        
Net Loss $ (57,107) $ (96,132) $ (63,778) $ (340,831)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 738 658 268 3,313
Stock-based compensation 3,507 4,880 2,759 23,688
Change in fair value of warrants (1,185) (6,050) (7,583) (11,956)
Loss on disposal of fixed assets 585 48 0 641
Common stock issued in exchange for in-process research and development 0 18,694 17,457 36,151
(Increase) decrease in:        
Receivables (87) 21 (79) (145)
Prepaid expenses and other current assets 4,964 (5,599) (889) (1,948)
Other noncurrent assets 473 (230) (407) (528)
Deposits 4 (43) (4) (128)
Increase (decrease) in:        
Accounts payable (1,087) (218) 696 422
Accrued expenses (10,159) 5,695 8,283 6,357
Deferred revenue (800) (800) 4,333 2,733
Deferred rent 625 244 109 1,063
Other noncurrent liabilities 20 0 0 20
Net cash used in operating activities (59,509) (78,832) (38,835) (281,148)
Cash flows from investing activities:        
Purchases of property and equipment (132) (1,559) (1,156) (4,758)
Proceeds from sale of property and equipment 1 0 0 2
Net cash used in investing activities (131) (1,559) (1,156) (4,756)
Cash flows from financing activities:        
Stockholders' capital contribution 0 0 0 500
Proceeds from exercise of stock options 956 30 980 2,329
Payments to employees for repurchase of restricted common stock (498) (546) (274) (3,364)
Proceeds from exercise of warrants 200 330 12,399 13,278
Proceeds from issuance of common stock and warrants, net 53,880 49,170 71,207 324,605
Proceeds from issuance of preferred stock, net 0 0 0 16,760
Net cash provided by financing activities 54,538 48,984 84,312 354,108
Net increase (decrease) in cash and cash equivalents (5,102) (31,407) 44,321 68,204
Cash and cash equivalents, beginning of period 73,306 104,713 60,392 0
Cash and cash equivalents, end of period 68,204 73,306 104,713 68,204
Supplementary disclosure of cash flow information:        
Cash paid for interest            
Cash paid for income taxes            
Supplementary disclosure of noncash investing and financing activities:        
Warrants issued to placement agents and investors 0 0 0 47,276
Exercise of liability-classified warrants to common shares 0 412 303 764
Convertible Preferred Stock
       
Supplementary disclosure of noncash investing and financing activities:        
Preferred stock conversion/exercise of equity-classified warrants to common stock 0 0 0 16,760
Warrants
       
Supplementary disclosure of noncash investing and financing activities:        
Preferred stock conversion/exercise of equity-classified warrants to common stock $ 196 $ 269 $ 9,067 $ 9,789